Abbott agrees to buy Alere at lower price

Abbott Laboratories agreed to buy Alere at a lower price following a legal battle over the deal.

The new transaction values Alere's equity at $5.3 billion, which is 8.6 percent less than the initial offer.

Abbott sued to break up the $5.8 billion takeover after arguing Alere hid material information about legal and regulatory problems, including bribery investigations.

Read more from Bloomberg.